About
A biotech entrepreneur and antibody engineer best known as co-founder and former CEO of Numab Therapeutics, which he built into a clinical-stage leader in multi-specific antibody therapeutics. He also co-founded Yellow Jersey Therapeutics whose lead asset was acquired by Johnson & Johnson in 2024 for approximately $1.25 billion.
Experience
- fourapesCommunity Foundation managercurrent2023 — presentDelaware, United States
- --Program manager at untitled companycurrent2019 — present
Education
- University of St.GallenBachelor's degree, Administration
Skills & more
GoKubernetesSocial Media MarketingRuby on RailsRustPython (Programming Language)SQLC++C#JavaC (Programming Language)JavaScript
+7 more
PostgreSQLSAP ProductsOracle DatabaseMySQLXcodeSwift (Programming Language).NET FrameworkFrom Dr.'s professional profile.
Colleagues at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners
Dr. Mattias Ivarsson
Entrepreneur in Residence at BioMedPartners
Frequently asked questions
- Where does Dr. David Urech work?
- Dr. David Urech is Venture Partner at BioMedPartners.
Same school
Also attended University of St.Gallen245
Melissa DonohoeVice President at Notion CapitalMarjolaine CatilPrincipal at Newfund CapitalGülce KoçInvestment Manager at IdacapitalDominik MatykaInvestor at Cavalry VenturesChristian NagelInvestor at Earlybird Venture CapitalKarol CieslukAssociate at TCV
+ 239 more